主题：【原创】关于转基因食品的2点意见 -- nimoheshu

世卫食品安全部门在2005年6月1日就转基因问题发布了一个长达79页的报告，题为《现代食品生物技术，人类健康与发展——以证据为基础的研究》，其中第24页明确写道：“目前国际市场上的转基因食品都经过了风险评估，它们并不比传统的同类食品有更多的风险。”

世界卫生组织网站：

http://www.who.int/foodsafety/biotech/who_study/en/index.html

3.6 Conclusions

GM foods currently available on the international market have undergone risk assessments and are not likely to present risks for human health any more than their conventional counterparts.

The risk-assessment guidelines specified by CAC are thought to be adequate for the safety assessment

of GM foods currently on the international market. Guidelines for environmental risk assessment have

been developed under the Convention on Biological Diversity.

The potential risks associated with GMOs and GM foods should be assessed on a case-by-case basis, taking into account the characteristics of the GMO or the GM food and possible differences of the receiving environments.

In the field of potential risks derived from outcrossing or contamination from GM crops, relevant consequences need to be investigated for specific crops, and strategies for risk management need to be explored.

As highlighted in the Codex Principles for the risk analysis of foods derived from modern biotechnology (CAC 2003b), the assessment of the potential of GM foods to elicit hypersensitivity reactions should be part of the risk assessment for GM foods. This includes a general analysis of the proteins expressed and assessment of the specific properties of the GM food under consideration to

elicit hypersensitivity reactions. A better understanding of the impact and interaction of food with the immune system is required to decipher how and whether conventional and GM foods cause specific health and safety problems.

New methodology for the development of GMOs may significantly reduce potential risks derived from the random integration of transgenes used in current methods.